Iodoxamic acid
Chemical compound
- V08AC01 (WHO)
- 3-{1-[(3-carboxy-2,4,6-triiodophenyl)carbamoyl]-3,6,9,12-tetraoxapentadecan-15-amido}-2,4,6-triiodobenzoic acid
- 31127-82-9
- 35740
- DB13539
- 32877
- NS1Y283HW4
- D01312
- ChEMBL1201324
- DTXSID4057710
- Interactive image
- OC(=O)c(c1I)c(I)cc(I)c1NC(=O)CCOCCOCCOCCOCCC(=O)Nc(c2I)c(I)cc(I)c2C(=O)O
Iodoxamic acid (trade name Endobil) is an organoiodine compound used as a radiocontrast agent.[1] It features both a high iodine content as well as several hydrophilic groups.
See also
- Iodinated contrast
References
- ^ Mützel W, Taenzer V, Wolf R (1976). "Biotransformation of ioglycamic acid, iodoxamic acid and iotroxic acid in man". Investigative Radiology. 11 (6): 598–601. doi:10.1097/00004424-197611000-00018. PMID 1036733.
- v
- t
- e
Contrast media (V08)
Iodinated, Water soluble |
| ||||||
---|---|---|---|---|---|---|---|
Iodinated, Water insoluble |
| ||||||
Non-iodinated |
Paramagnetic | |
---|---|
Superparamagnetic |
|
Other |
- Microspheres of human albumin
- Microparticles of galactose
- Perflenapent
- Microspheres of phospholipids
- Sulfur hexafluoride
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e